- May 2021 |
- Healthcare & Pharmaceutical / Healthcare Services
Global Leukapheresis Market, By Product Type (Devices, Filters, Columns, Disposables); By Application (Research Applications, Therapeutic Applications); By Indication (ALL [Acute Lymphocytic Leukemia], NHL [Non-Hodgkin’s Lymphoma], Multiple Myeloma); By End-User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Center of Research Organization (CRO), and Others); By Region (North America, Europe, the Asia-Pacific, the Middle East & Africa, and Latin America) Trend Analysis, Competitive Market Share & Forecast, 2017-2027
The Global Leukapheresis Market-
Industry Trends & Forecast Report 2027
The global leukapheresis market was worth USD 51.6 billion in 2020, and is further projected to reach USD 87.5 billion by 2027, at a CAGR of 7.8% during 2021-2027 (forecast period). The leukapheresis procedures are performed to determine the cause of a decline in white blood cell counts Increasing incidence and prevalence of leukemia disease, demand for leukopaks for research applications, and an increase in blood donations are some of the factors driving the market demand. Furthermore, pharmaceutical and biopharmaceutical companies have been growing their investment in medical research and development, which contributes to the overall market growth.
Source: BlueWeave Consulting
Global Leukapheresis Overview
Leukapheresis is a medical procedure that separates white blood cells (leukocytes) involved in the body's immune response from a blood sample. It is a type of apheresis in which a component of blood is extracted while the remaining blood is returned to circulation. Leukapheresis is often used to decrease very high white blood cell (WBC) counts such as can occur with chronic blood cancers like chronic lymphocytic leukemia (CLL). It can also be used to collect white blood cells for later transplant, such as to treat sharp declines in WBC counts caused by cancer chemotherapy.
Global Leukapheresis Market Trend
Rising Cases and Prevalence of Leukemia
Leukemia is a type of blood cell cancer. Blood cells are classified into three types: red blood cells (RBCs), white blood cells (WBCs), and platelets. Leukemia, in general, refers to cancers of the white blood cells. The rising incidence and prevalence of leukemia have risen significantly because of the genetic history of leukemia (inherited) and excessive smoking by pregnant women, which infects their blood and weakens their immune system. In 2020, the American Cancer Society estimated that there are 60,530 leukemia cases in the United States, owing to which the number of therapeutic leukapheresis procedures is increasing, thereby boosting the growth for the global leukapheresis market. Consumption of leukopaks has risen dramatically due to an increase in leukemia cases worldwide. Furthermore, since leukopaks are generated from normal peripheral blood and are transfused into infected bodies, the increased use of leukopaks fuels the growth of the global leukapheresis industry.
Rise of Leukapheresis in Pediatric Patients
According to the Leukemia & Lymphoma Community, 7.2 children...